Dispersed guinea-pig adrenal cells have been employed in the in vitro estimation of the biological potency and sites of action of drugs acting against the adrenal. The effect of 12 drugs on cortisol secretion from cells stimulated with adrenocorticotrophin (ACfH, 50 ngIL, a 95% saturating dose) has been tested. All the drugs depressed cortisol output in a dose-related fashion. The concentration of drug which inhibited secretion by 50% was (!J.moVL, mean±SEM): etomidate 0·1 ±O·OO2; epostane O·44±O·02: 17-ketotrilostane O·55±O·04: trilostane I·3±O·I: metyrapone 3·5±O·6: cyproterone acetate 4·6±O·2: megestrol acetate 11±2: danazol 22±2: aminoglutethimide 4I±5: stanozolol 50±4: thiopentone 160±I8: propofol 170± 18.
We have recently described two systems in which we have exploited the characteristics of dispersed guinea-pig adrenal cells maintained in primary cell culture': 2 in the assessment of the in vitro anti-steroidogenic potency of various drugs>-5 and in the delineation of the enzymic sites of action of these inhibitory effects. [5] [6] [7] The first system" is based upon the druginduced inhibition of ACTH-stimulated cortisol production by dispersed adrenal cells. The drugs employed were arninoglutethimide, metyrapone, trilostane, 17-ketotrilostane and epostane (all known anti-steroidogenic compounds), danazol (an anti-gonadotrophic agent), megestrol acetate (a synthetic progestagen), stanozolol (an anabolic steroid) and cyproterone acetate (an anti-androgen). In view of the association between the anaesthetic, etomidate, This paper was the Ames Award winning lecture presented at the Association of Clinical Biochemists' National Meeting held in Cardiff in 1985. Correspondence: A. Lambert. adrenocortical suppression and mortality, this drug and two other anaesthetics, propofol and thiopentone, have also been tested.
The second system" is based upon the ability of dispersed adrenal cells to synthesise cortisol in the absence of ACTH when challenged with high concentrations of precursor steroid molecules on the pathway to cortisol synthesis ( Fig. 1 ). An exception to this is found with cholesterol. Basal cortisol secretion by adrenal cells cannot be increased by challenging the cells with high concentrations of cholesterol since the conversion of cholesterol to pregnenolone requires the mediation of ACfH. The inhibitory effect of a drug will only be observed if the stimulator is before the site of action of that compound. Thus, for example, any drug which inhibits t}5, 3~hydroxysteroid dehydrogenase activity will be without effect on cortisol secretion induced by the L\ 4 , 3 keto steroids, 17-hydroxyprogresterone and 11deoxycortisol, but will block ACTH, preg-nenolone and 17-hydroxy-pregnenolone stimulated cortisol output (Fig. 1) .
The data contained in the manuscr~t has been presented in a series of papers, 7 has been recently reviewed" and was prepared as the Ames Award lecture presented by Dr A Lambert at the Association of Clinical Biochemists' Meeting (Cardiff, 1985) .
Materials and methods

PREPARATION OF ISOLATED GUINEA-PIG
ADRENAL CELLS
Dispersed guinea-pig adrenal cells were prepared as described previously': 2 except that collagenase was used instead of trypsin. The adrenals from two male guinea-pigs were chopped into 1 mm cubes using a McIlwain tissue chopper, the tissue pieces washed with Eagle's minimum essential medium (EMEM) and dispersed by mechanical agitation in EMEM contairnng collagenase (2 mglmL). The cells were collected by centrifugation (300 g for 5 min) and washed twice with Eagle's medium containing bovine serum albumin (BSA 0,5%), calcium (8 x 10-3 mol/L) and ascorbate (2 x 10-3 mol/L), The above mixture served as incubation medium. Finally, the cell suspension was filtered through nylon (100 u) mesh. The cells (1 x 10 6 cells/mL) were then preincubated for 2 h at 37°C in an atmosphere of 100% O 2 , After pre-incubation the cell suspension was centrifuged to remove any secreted cortisol and resuspended in fresh incubation medium.
In the first set of experiments, aliquots (40 Ill) of cell suspension were dispensed into a 96-well tissue culture plate and stimulated for 90 min at 37°C with 50 ng/L ACTH (1-24) either alone or in combination with increasing concentrations of the drugs (10-9_10-4 mol/L). The drugs were generally incorporated into cell suspension in dimethylsulphoxide (DMSO) such that the final concentration of solvent was 2·5%. In some experiments thipentone was incorporated into the cell suspension in aqueous medium (EMEM). When appropriate, DMSO (2'5%) was also included in the basal (no added ACTH) and ACTH (50 ng/L) stimulated wells. The total volume of incubate in each well was 80 III and the final cell concentration was 0·75 x 10 6 cells/mL. After 90 min incubation, duplicate 10 ul, samples were taken and assayed for cortisol by radioimmunoassay. None of the drugs interfered with the radioimmunoassay at the concentrations employed.
In the second set of experiments, the cells were stimulated with the cortisol precursor steroids (all at 10-5 mol/L) pregnenolone, 17-hydroxypregnenolone, 17-hydroxyprogresterone and ll-deoxycortisol, or with either dibutyryl cyclic AMP (10-3 rnol/L) or ACTH (100 ng/L) in the presence or absence of either cyproterone acetate (10-5 mol/L), etomidate, metyrapone, trilostane , megestrol acetate (5 x 10-5 rnol/L), propofol (2·5 x 10-4 rnol/L) or thiopentone (5 x 10-4 rnol/L). After the 90 min incubation period, cortisol was assayed by radioimmunoassay. drug was > 1500 times more potent than the other two anaesthetics, propofol and thiopentone, and 13, 36 and 423 times more potent than the established anti-adrenal drugs trilostane, metyrapone and aminoglutethimide. The effect of ACTH-stimulated and steroid (2) 11±2
(2) 22±2 (6) 41±5 (5) 
50H
(2)
160±18
(3) 170±18 (3) precursor (pregnenolone. 17-hydroxypregnenolone, 17-hydroxyprogesterone and 11deoxycortisol) provoked cortisol secretion by adrenal cells in the presence or absence of either propofol (2·5 x 10-4 mollL) , (.) . . megestrol acetate (5 x W-5 mollL) or etomidate (5 x 10-5 mollL) is shown in Fig. 3 . All these stimulators gave rise to a > 7-fold increase in cortisol output over that seen in their absence. Similar experiments have been performed for trilostane, cyproterone acetate, metyrapone and thiopentone. Propofol (Fig. 3a) depressed ACfH-induced cortisol output by > 60% (P«)-(15) but was without effect when the steroid precursors were employed. In contrast, megestrol acetate (Fig.  3b , also trilostane and cyproterone acetate, data not shown) had no effect on cortisol production when the~4, 3-keto steroids 17hydroxyprogesterone and II-deoxycortisol were used. but inhibited secretion provoked by all the other stimulators by > 60% (P«)'(15).
Finally. etomidate (Fig. 3c , also metyrapone and thiopentone. data not shown) suppressed cortisol output by > 60% (P«).(15) with all the stimulators employed.
Discussion
Two in vitro systems:' h have been developed using dispersed cells maintained in primary cell culture which allow a rapid assessment of the biopotency and site of action of various drugs acting against endocrine tissues. These techniques have proved particularly valuable in the study of agents affecting steroidogenic tissues'': 4. h. 7 and can be applied to other types of endocrine cells (e.g. thyrocytes" and Leydig cells. 5 ) The anti-steroidogenic effects of 12 drugs of different structure and therapeutic action have been studied using the dose-related inhibition of cortisol secretion from adrenal cells." 4. 7 Anti-adrenal steroidogenic activity has been confirmed for metyrapone, aminoglutethimide, trilostane, 17-ketotrilostane and epostane. Further, direct effects have been demonstrated for the first time for danazol, megestrol acetate, stanozoloJ. cyproterone acetate and the anaesthetics. Of the latter, thiopentone and propofol were only weak inhibitors whilst etomidate was by far the most potent drug investigated.
The guinea-pig adrenal cell system has been used in delineation of the site of action of some drugs on adrenal steroidogenesis. By challenging the adrenal cells with the cortisol precursor steroids. (Pregnenolone, 17-hydroxy pregnenolone, I7-hydroxyprogesterone, ll-deoxycortisol) in the presence and absence of drug, we have established the site of action of etomidate, metyrapone and thiopentone (II~hydroxy-lase)5.6 trilostane and megestrol acetate (3h ydroxysteroid dehydrogenase, 3~HSD),6 cyproterone acetate (3~HSD and 21 hydroxylase)" and propofol (ACTH bindingpregnenolone productionj.?
In conclusion, these studies emphasise the potential pharmacological value of dispersed cell techniques in investigating the effects and sites of action of drugs on endocrine tissues. The principles and techniques described may have wide application in the biological screening of new and existing compounds. Further, such approaches could lead to the development of in vitro bioassays for drugs in plasma.
